MILFORD, Mass., Dec. 21, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 8, 2024 at 7:30PM Eastern Time (4:30PM Pacific Standard Time (PST)).
A live webcast of the event will be available on the 'Events & Presentations' section of Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.
About Waters Corporation
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
Source: Waters Corporation
Caspar Tudor, Head of Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$347.31 |
| Daily Change: | -12.69 -3.52 |
| Daily Volume: | 542,326 |
| Market Cap: | US$20.620B |
October 10, 2024 October 08, 2024 August 14, 2024 July 31, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
